Showing results (761-770 of 847) with videos related to
Sort By:
Pageof 85
Clinical and Molecular Hepatology|March 12, 2024
Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world studyYoung Eun Chon, Dong Yun Kim, Mi Na Kim, et al.Journal of Gastroenterology and Hepatology|August 10, 2016
Conventional versus drug-eluting beads chemoembolization for hepatocellular carcinoma: Emphasis on the impact of tumor sizeYong Kang Lee, Kyu Sik Jung, Do Young Kim, et al.Magnetic Resonance Imaging|April 17, 2010
Can preoperative diffusion-weighted MRI predict postoperative hepatic insufficiency after curative resection of HBV-related hepatocellular carcinoma? A pilot studySeung Up Kim, Young Chul Kim, Ji Soo Choi, et al.Journal of Gastroenterology and Hepatology|January 21, 2023
The clinical effect of antiviral therapy in patients with hepatitis B virus-related decompensated cirrhosis and undetectable DNAHan Ah Lee, Young-Sun Lee, Young Kul Jung, et al.Molecular Cell|July 7, 2021
SREBP-1c impairs ULK1 sulfhydration-mediated autophagic flux to promote hepatic steatosis in high-fat-diet-fed miceThuy T P Nguyen, Do-Young Kim, Yu-Geon Lee, et al.Plos One|June 6, 2014
Factors affecting the accuracy of controlled attenuation parameter (CAP) in assessing hepatic steatosis in patients with chronic liver diseaseKyu Sik Jung, Beom Kyung Kim, Seung Up Kim, et al.Journal of Hepatology|January 26, 2016
Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trialRiccardo Lencioni, Josep M Llovet, Guohong Han, et al.European Journal of Gastroenterology & Hepatology|February 4, 2020
Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis CHo Soo Chun, Beom Kyung Kim, Jun Yong Park, et al.Antiviral Therapy|June 21, 2011
Partial virological response to entecavir in treatment-naive patients with chronic hepatitis BYoung Eun Chon, Seung Up Kim, Chun Kyon Lee, et al.Gut and Liver|July 9, 2021
Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver DiseaseYuna Kim, Eugene Han, Jae Seung Lee, et al.Pageof 85